Klin Padiatr 2018; 230(06): 340
DOI: 10.1055/s-0038-1675276
Georg Thieme Verlag KG Stuttgart · New YorkCombined Bcl-2/Bcl-xL and RAC1 inhibition yields a synergistic antineoplastic activity
in glioblastoma
M Hlavac
1
Department of Neurosurgery, Ulm University Medical Center, Ulm, Germany
,
A Dwucet
1
Department of Neurosurgery, Ulm University Medical Center, Ulm, Germany
,
A Westhoff
2
Department of Pediatric and Adolescent Medicine, Ulm University Medical Center, Ulm,
Germany
,
RE Kast
3
IIAIGC Study Center, Burlington, VT, USA
,
J Engelke
1
Department of Neurosurgery, Ulm University Medical Center, Ulm, Germany
,
MD Siegelin
4
Department of Pathology, Columbia University Medical Center, New York, USA.
,
CR Wirtz
1
Department of Neurosurgery, Ulm University Medical Center, Ulm, Germany
,
ME Halatsch
1
Department of Neurosurgery, Ulm University Medical Center, Ulm, Germany
,
G Karpel-Massler
1
Department of Neurosurgery, Ulm University Medical Center, Ulm, Germany
› Author Affiliations
